IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 30.09.2024
de en
Business reportPerformance / Multi-year comparison

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Rolling performance

SHARE

NAV

NBI TR

30.09.2023 – 30.09.2024

(8.1%)

5.2%

12.3%

30.09.2022 – 30.09.2023

(17.1%)

(12.8%)

(1.7%)

30.09.2021 – 30.09.2022

(33.7%)

(22.7%)

(21.3%)

30.09.2020 – 30.09.2021

31.1%

24.5%

21.9%

30.09.2019 – 30.09.2020

15.9%

21.0%

26.4%

Annual performance

SHARE

NAV

NBI TR

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

2019

18.5%

23.4%

23.0%

Cumulated performance

30.09.2024

SHARE

NAV

NBI TR

YTD

(11.1%)

0.3%

10.5%

1 year

(8.1%)

5.2%

12.3%

3 years

(49.5%)

(29.1%)

(13.1%)

5 years

(23.2%)

6.8%

33.9%

10 years

60.4%

43.8%

56.5%

since inception 1)

1 660%

1 865%

1 331%

1 09.11.1993

Annualized performance

30.09.2024

SHARE

NAV

NBI TR

1 year

(8.1%)

5.2%

12.3%

3 years

(20.4%)

(10.8%)

(4.6%)

5 years

(5.2%)

1.3%

6.0%

10 years

4.8%

3.7%

4.6%

since inception 1)

9.7%

10.1%

9.0%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Rolling performance

SHARE

NAV

NBI TR

30.09.2023 – 30.09.2024

(4.7%)

8.2%

15.4%

30.09.2022 – 30.09.2023

(17.3%)

(12.9%)

(2.1%)

30.09.2021 – 30.09.2022

(26.1%)

(13.9%)

(11.7%)

30.09.2020 – 30.09.2021

29.6%

24.5%

21.8%

30.09.2019 – 30.09.2020

17.5%

22.0%

27.3%

Annual performance

SHARE

NAV

NBI TR

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

2019

23.4%

28.1%

27.6%

Cumulated performance

30.09.2024

SHARE

NAV

NBI TR

YTD

(11.0%)

(1.0%)

9.0%

1 year

(4.7%)

8.2%

15.4%

3 years

(41.7%)

(18.8%)

(0.2%)

5 years

(11.2%)

23.4%

54.7%

10 years

105%

84%

100%

since inception 1)

1 524%

1 712%

1 498%

1 10.12.1997

Annualized performance

30.09.2024

SHARE

NAV

NBI TR

1 year

(4.7%)

8.2%

15.4%

3 years

(16.5%)

(6.7%)

(0.1%)

5 years

(2.4%)

4.3%

9.1%

10 years

7.5%

6.3%

7.2%

since inception 1)

10.9%

11.4%

10.9%

1 10.12.1997

Multi-year comparison

30.09.2024

2023

2022

2021

2020

Market capitalization at the end of the period (in CHF mn)

2 016.6

2 368.4

3 058.1

4 274.1

4 107.9

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

2 229.0

2 323.2

2 686.1

3 283.5

3 887.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

710.3

906.3

1 482.0

2 101.0

2 315.6

highchart-toggle

Profit/(loss) (in CHF mn)

16.2

(206.6)

(357.8)

(404.8)

691.2

highchart-toggle

Closing price at the end of the period in CHF

36.40

42.75

55.20

77.15

74.15

highchart-toggle

Closing price at the end of the period in EUR

38.80

45.50

56.70

74.05

68.00

highchart-toggle

Stock performance (incl. distributions) 1)

(11.1%)

(18.1%)

(24.3%)

8.3%

19.3%

highchart-toggle

High/low share price in CHF

49.35/36.40

60.70/35.60

78.15/51.00

92.20/73.40

74.70/45.44

highchart-toggle

High/low share price in EUR

52.00/38.30

60.50/37.10

75.40/49.60

86.20/67.80

69.00/43.04

highchart-toggle

Premium/(discount) (annual average)

(3.8%)

7.5%

20.5%

19.5%

9.2%

highchart-toggle

Dividend in CHF

N.A.

2.00

2.85

3.85

3.60

highchart-toggle

Degree of investment (quarterly figures)

113.3%

113.7%

112.8%

108.6%

106.8%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.34%

1.34%

1.27%

1.22%

1.25%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization